Attovia Therapeutics Inc. (ATTO)

Profile

https://www.attovia.com

Attovia Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for immune-mediated diseases. Its work centers on the ATTOBODY biologics platform, which is used to design precision medicines aimed at inflammatory and immune-driven conditions. The company’s current pipeline includes programs for chronic pruritic and inflammatory skin diseases, such as atopic dermatitis and related itch disorders, as well as candidates targeting inflammatory bowel disease and other immune-mediated indications. Attovia Therapeutics Inc. develops its product candidates as biotherapeutics intended to address high unmet medical needs through targeted mechanisms and differentiated biologic formats. Based in San Carlos, California, the company operates in the biotechnology and medical research sector, where its platform-based approach supports the discovery and development of multi-specific therapies for complex diseases.